IDH1/IDH2 mutation

Clinical trials for IDH1/IDH2 mutation explained in plain language.

Never miss a new study

Get alerted when new IDH1/IDH2 mutation trials appear

Sign up with your email to follow new studies for IDH1/IDH2 mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Brain tumor drug delivered via pump shows promise in early trial

Disease control Recruiting now

This early-phase study tests the safety of delivering the chemotherapy drug topotecan directly to the brain using a pump and catheter system (convection-enhanced delivery) in 6 people with a recurrent, aggressive type of brain tumor called IDH-mutant malignant glioma. The treatme…

Matched conditions: IDH1/IDH2 MUTATION

Phase 1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

IDH1/IDH2 mutation

Get alerted when new IDH1/IDH2 mutation trials appear

Brain tumor drug delivered via pump shows promise in early trial